– CLANWILLIAM GROUP INVESTS IN ANALYTICAL MEDICAL INSIGHT –
We are pleased to announce an investment from Clanwilliam Group which will be used to strengthen current AMI product offerings as well as provide additional development capability for future product innovations.
Commenting on the investment, Dr. Seán Higgins, founder and Managing Director of AMI said:
“We are delighted with the financial support provided by Clanwilliam Group. The extra resources made available to us will enable our team to further develop our products for the benefit of our customers, as well as accelerate our growth ambitions in the UK and Ireland. While I will remain Managing Director of AMI I am also happy to announce that I will be joining Clanwilliam Group’s clinical advisory team which includes Doctors, Pharamacists and Clinical Professionals that help guide and influence a number of Clanwilliam Group companies’ product innovation strategies.”
Speaking on the investment and Dr. Higgins’ recent appointment, Jennifer Hughes, Director of Marketing at Clanwilliam Group said:
“At Clanwilliam Group, we are ambitious for the future of the ehealth sector in Ireland and the UK. Our strategy to invest in emerging healthcare technology companies like AMI, who share our vision for what technology can achieve in healthcare, is designed to help drive the ehealth agenda and help improve healthcare for everyone. We are also delighted to welcome Dr. Sean Higgins to our expanding clinical advisory team. We recognise that there are certain clinical aspects of our products’ functionality where only healthcare professionals will have the required knowledge and expertise to contribute to the design of our systems. With our clinical advisory team, user group forums and ongoing customer feedback, not only can our customers voice their suggestions and product ideas, they now have front row access to affect change through product development strategies.”